Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Medical Device_Diagnostics
Ellume

Organization & Developments: Ellume

Parents

2020: FDA Authorizes Ellume COVID-19 Home Test as First Over-the-Counter Fully At-Home Diagnostic Test
2021: A single-use, digital fluorescent immunoassay antigen test for SARS-CoV-2 and influenza A/B all-in-one platform. Results are returned in 15 minutes or less. The platform is paired with a mobile app for ease of use and is intended for use in point-of-care settings.
2021: DoD awards Ellume $231M to increase US production of at-home, OTC COVID-19 test
2021: Ellume_Fierce 15
2021: Rapid at-home coronavirus tests will soon be more widely available to Americans
2021: US makes deal with Ellume for 8.5 million a month
Ellume has a global consumer health partnership with GlaxoSmithKline, a global COVID-19 and latent TB partnership with QIAGEN
Ellume is a digital diagnostics company that develops, manufactures, and commercializes high-performance, connected products for healthcare professionals and consumers.
Ellume is at the forefront of accurate, rapid and accessible testing that is integral to today’s COVID-19 response and will help ensure the world is prepared for the next infectious disease pandemic.